‘Seeing through the Smoke,' Dr. Peter Grinspoon Showcases New Book
Physician and cannabis expert, Dr. Peter Grinspoon, has released his new book titled,”Seeing through the Smoke.” In this informative piece of literature, Dr. Grinspoon discusses separating fact from fiction, cannabis research, and a guide on how to use cannabis safely.
The cannabis industry is growing every day with more support. According to Dr. Peter Grinspoon's new book (1), one in seven Americans use a type of cannabidiol (CBD) product. Additionally, 94% of Americans support the legalization of medical cannabis and 69% wish to see total legalization. In this book, Dr. Grinspoon will cover how spiked research was done in the past to devalue the medicinal properties of cannabis and aimed to find harm. The cannabis used for testing now with the government is unfit to yield quality data. One thing Dr. Grinspoon encourages and hopes to see change is for medical professionals, such as other doctors, to educate themselves on cannabis.
“Throughout the second half of the nineteenth century and right up until 1937, when cannabis became effectively prohibited in the United States by the Marihuana Tax Act, doctors routinely prescribed cannabis tinctures and considered it to be an effective, mainstream medicine,” Grinspoon mentions in his book. He hopes that his new book will help inform but also guide readers on their cannabis journeys.
Reference
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
